C25H29NO10
Neat
503.50
-20°C
Room Temperature
Naloxone-3-glucuronide; 22135-79-1; 86O922U8J0; beta-D-Glucopyranosiduronic acid, (5alpha)-4, 5-epoxy-14-hydroxy-6-oxo-17-(2-propenyl)morphinan-3-yl; RefChem:164465; Naloxone 3-b-D-glucuronide; UNII-86O922U8J0; Naloxone 3-ss-D-Glucuronide; (2S, 3S, 4S, 5R, 6S)-6-[[(4R, 4aS, 7aR, 12bS)-4a-hydroxy-7-oxo-3-prop-2-enyl-2, 4, 5, 6, 7a, 13-hexahydro-1H-4, 12-methanobenzofuro[3, 2-e]isoquinolin-9-yl]oxy]-3, 4, 5-trihydroxyoxane-2-carboxylic acid; Naloxone-3-Beta-D-glucuronide; Naloxone 3-?-D-Glucuronide; Naloxone 3-b-D-Glucuronide (1.0mg/ml in DMSO); Naloxone 3-O-beta-D glucuronide; Naloxone 3-b-D-Glucuronide (1 mg/ml in DMSO); Q27269752; Naloxone-3-Beta-D-glucuronide, 1mg/ml in Methanol/Water : 1/1; .BETA.-D-GLUCOPYRANOSIDURONIC ACID, (5.ALPHA.)-4 and 5-EPOXY-14-HYDROXY-6-OXO-17-(2-PROPENYL)MORPHINAN-3-YL
(2S, 3S, 4S, 5R, 6S)-6-[[(4R, 4aS, 7aR, 12bS)-4a-hydroxy-7-oxo-3-prop-2-enyl-2, 4, 5, 6, 7a, 13-hexahydro-1H-4, 12-methanobenzofuro[3, 2-e]isoquinolin-9-yl]oxy]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C25H29NO10/c1-2-8-26-9-7-24-15-11-3-4-13(34-23-18(30)16(28)17(29)20(36-23)22(31)32)19(15)35-21(24)12(27)5-6-25(24,33)14(26)10-11/h2-4,14,16-18,20-21,23,28-30,33H,1,5-10H2,(H,31,32)/t14-,16+,17+,18-,20+,21+,23-,24+,25-/m1/s1